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Purpose: The aim of this prospective, double-blind, randomized study was to in-
vestigate the analgesic effects of low-dose ketamine on intravenous patient-con-
trolled analgesia (IV-PCA) with fentanyl for pain control in pediatric patients fol-
lowing the Nuss procedure for pectus excavatum. Materials and Methods: Sixty 
pediatric patients undergoing the Nuss procedure were randomly assigned to re-
ceive fentanyl (Group F, n=30) or fentanyl plus ketamine (Group FK, n=30). Ten 
minutes before the end of surgery, following the loading dose of each solution, 0.5 
μg/kg/hr of fentanyl or 0.5 μg/kg/hr of fentanyl plus 0.15 mg/kg/hr of ketamine 
was infused via an IV-PCA pump (basal rate, 1 mL/hr; bolus, 0.5 mL; lock out in-
terval, 30 min). Fentanyl consumption, pain score, ketorolac use, nausea/vomiting, 
ondansetron use, pruritus, respiratory depression, hallucination, dreaming, and par-
ent satisfaction with pain control were measured throughout the 48 hours follow-
ing surgery. Results: The pain scores, ketorolac use, and fentanyl consumption of 
Group FK were significantly lower than in Group F (p<0.05). The incidence of 
nausea/vomiting and ondansetron use in Group FK was significantly lower than in 
Group F (p<0.05). There were no reports of respiratory depression, hallucination or 
dreaming. Parent satisfaction with pain control was similar between the two groups. 
Conclusion: We concluded that low-dose ketamine added to IV-PCA with fentanyl 
after the Nuss procedure in pediatric patients can reduce pain scores, consumption 
of fentanyl, and incidence of nausea/vomiting without increasing side effects.
Key Words:    Fentanyl, funnel chest, ketamine, patient-controlled analgesia, pedi-
atrics
INTRODUCTION
Pectus excavatum is a congenital deformity in which the sternum and the inferior 
costal cartilage area are depressed. Nuss, et al.1 described the Nuss procedure to 
correct pectus excavatum using specially made metal rods fitted to the chest defor-
mity of the patient. Bending of the rod pushes against the depressed costa and ster-
num, thereby restoring the chest to its normal shape. The procedure has excellent Moon Ho Cha, et al.
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Acemedical, Seoul, Korea) were excluded. 
One hour prior to the induction of anesthesia, 0.1 mg/kg 
of atropine was injected intramuscularly as premedication. 
An IV line was introduced and a dextrose/saline solution 
was infused at 4 mL/kg/hr during the operation. Anesthesia 
was induced by 5 mg/kg of thiopental sodium and 0.6 mg/
kg of rocuronium. After the trachea was intubated, anesthe-
sia was maintained with 1.5 L/min of oxygen, 1.5 L/min of 
nitrous oxide and 1.5-2.5 vol% of sevoflurane. Throughout 
the operation, blood pressure, electrocardiogram, end-tidal 
carbon dioxide concentration and pulse oximetry saturation 
were routinely monitored. 
Ten minutes before the end of surgery, a loading dose of 
1 μg/kg of IV fentanyl or 1 μg/kg of IV fentanyl plus 0.3 
mg/kg of IV ketamine was injected for respective each 
group. Subsequently, 0.5 μg/kg/hr of fentanyl or 0.5 μg/kg/
hr of fentanyl plus 0.15 mg/kg/hr of ketamine was infused 
via an IV-PCA pump with a basal rate of 1 mL/hr respec-
tively to each group. Drug concentrations were prepared for 
each patient according to his/her body weight, totaling 1 
mL of drug preparation comprising 0.5 μg/kg of fentanyl or 
0.5 μg/kg of fentanyl plus 0.15 mg/kg of ketamine for each 
group. When patients experienced pain, they or their guard-
ians pushed the demand button, and, thereafter, a 0.5 mL 
drug bolus, comprising 0.25 μg/kg of fentanyl or 0.25 μg/
kg of fentanyl plus 0.075 mg/kg of ketamine for each re-
spective group, was injected. The frequency of bolus injec-
tion was limited to two times per one hour. The total vol-
ume of IV-PCA medication was determined to be 100 mL, 
corresponding to 50 μg/kg of fentanyl or 50 μg/kg of fen-
tanyl plus 15 mg/kg of ketamine for each group, i.e. the 
maximum dose over 48 hours. The intensity of pain was as-
sessed using a visual analogue scale (VAS) ranging from 0 
(no pain) to 10 (worst imaginable pain). VAS and cumula-
tive fentanyl consumption were measured at 1, 6, 12, 24, 
and 48 hours after the surgery. For patients who responded 
with pain greater than 4 on the VAS, 0.5 mg/kg of IV ketor-
olac was administered and the administration was recorded.
A blinded anesthesiologist assessed and recorded the de-
velopment of side effects including nausea/vomiting, pruri-
tus, respiratory depression, hallucination, and dreaming at 
1, 6, 12, 24, and 48 hours after surgery. Nausea was defined 
as the subjective sensation of discomfort associated with 
the awareness of the urge to vomit. Vomiting was defined as 
a forceful expulsion of gastric contents through the mouth. 
In cases of severe nausea/vomiting, or nausea/vomiting that 
did not resolve, we administered 0.1 mg/kg of IV ondanse-
esthetic results and helps improve lung function. However, 
the Nuss procedure can induce severe postsurgical pain due 
to the expansion of the thorax. This pain can be controlled 
with intravenous patient-controlled analgesia (IV-PCA) us-
ing opioids.2-4
Strong pain stimuli activate N-methyl-D-aspartate (NMDA) 
receptors and produce hyperexcitability of dorsal root neu-
rons.5 This trigger induces central sensitization, the wind-up 
phenomenon, and pain memory. An NMDA receptor antag-
onist can prevent the induction of central sensitization caused 
by stimulation of peripheral nociception as well as by block-
ing the wind-up phenomenon.5 When used in a large dose 
for a prolonged period as well as at the very early stage of 
therapy, opioids can induce hyperalgesia and tolerance, 
which may lead to increased postoperative pain.6,7 Increased 
postoperative pain, in turn, leads to the need for higher dos-
es of opioids. Ketamine, by blocking NMDA receptors, can 
prevent the development of central sensitization and opioid 
resistance.5,7 Therein is the basis for using ketamine as an 
adjuvant to opioids in postoperative pain control. 
However, clinical trials of ketamine added to IV-PCA with 
opioids in postoperative pain control have demonstrated con-
tradictory results.8-11 The effects of ketamine combined with 
fentanyl in IV-PCA for postoperative pain control for the 
Nuss procedure have not been examined. Therefore, we in-
vestigated the analgesic effects of low-dose ketamine on IV-
PCA with fentanyl for pain control following the Nuss proce-
dure for pectus excavatum repair in pediatric patients.
MATERIALS AND METHODS
　　　
This prospective, double-blind randomized study was ap-
proved by the Institutional Review Board. Written informed 
consent for the study was obtained from the parents of all 
children enrolled in the study. Sixty children, American So-
ciety of Anesthesiologists physical status I or II, aged 6-16 
years, who underwent the Nuss procedure for repair of pec-
tus excavatum were enrolled in this study. The patients were 
divided randomly into two groups. Group F was given fen-
tanyl only, and Group FK was given fentanyl plus ketamine. 
The equipment and procedure were explained in detail. Pa-
tients with congenital heart disease, lung parenchymal dis-
ease, gastrointestinal disease, psychiatric disease, skin dis-
ease, a history of motion sickness or postoperative nausea/
vomiting, drug contraindications, or who were unable to un-
derstand how to use the IV-PCA device (AutoMed 3200, Effects of Adding Ketamine to Fentanyl IV-PCA
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as mean±SD or as the number of patients (%). Statistical 
analyses were performed using the statistical software pack-
age SPSS version 12 for Windows (SPSS Inc., Chicago, IL, 
USA). For numerical variables, independent t-tests were 
employed to compare inter-group differences and chi-square 
or Fisher’s exact tests were adopted for categorical vari-
ables. Differences were regarded as statistically significant 




Sixty five patients were assessed for eligibility. Three pa-
tients were not included in the study due to being younger 
than 6 years of age. Two patients were excluded due to his-
tory of motion sickness. In total, sixty patients were enrolled 
for the study. Thirty patients were randomly allocated to 
each group (Fig. 1). Gender, age, weight, and duration of an-
esthesia were not significantly different between the two 
groups (Table 1). 
The VAS pain scores of Group FK were significantly 
lower than those of Group F at 6, 24, and 48 hours after sur-
gery (p<0.05) (Table 2). There were 7 (23%) patients who re-
quired additional analgesic, ketorolac, during the 48 hours 
after surgery, in Group FK, significantly lower than the 18 
patients (53%) in Group F (p<0.01). 
The cumulative fentanyl consumption was significantly 
reduced in Group FK compared to Group F, at 24 and 48 
hours after surgery (p<0.05) (Table 3). 
tron. Pruritus was defined as the subjective sensation of 
itching without skin lesions and was treated with 0.1 mg/kg 
of IV chlorophenyramine or 1 μg/kg of IV naloxone, in se-
vere cases only. Respiratory depression was defined as pulse 
oximetry saturation levels less than 90% at room air or a 
respiration rate less than 10/min. Respiratory depression, if 
present, was managed with oxygen insufflation via nasal 
cannula at 5 L/min. When respiratory depression was not 
corrected by oxygen insufflations, 1 μg/kg of IV naloxone 
was administered. If the respiratory depression was still not 
corrected by these measures, the IV-PCA infusion rate was 
to be reduced by 50% every hour, until it was resolved. Res-
piration rate and pulse oximetry saturation were to be moni-
tored throughout these measures until the respiratory depres-
sion was resolved. Hallucination and dreaming were defined 
as any sensation that was not caused by an external event, 
and if present, the IV-PCA infusion rate would be reduced 
by 50% every hour, until symptoms were resolved. Overall 
parent satisfaction with pain control was determined at 48 
hours after surgery as either satisfactory or unsatisfactory. 
Michelet, et al.9 hypothesized a 25% reduction in mor-
phine consumption with an expected standard deviation of 
30% in a calculated sample size of 24 subjects per group, 
detecting a difference with a power of 0.80 and a 5% risk of 
type I error. Based on their study,9 we expected that fentan-
yl plus ketamine IV-PCA could reduce fentanyl consump-
tion by 25% in a sample size of 24 patients per group with 
the same statistical power. We planned to enroll enough pa-
tients to obtain 30 patients per group. Values were expressed 
Fig. 1. Flow diagram of the progress through the trial. Group F, fentanyl 
group; Group FK, fentanyl plus ketamine group.
Table 1. Patient Characteristics 




Sex (M/F) 23/7 25/5
Age (yrs) 10.2±2.9   9.9±2.7
Weight (kg) 34.4±9.2 31.2±8.9
Duration of anesthesia (min) 106.0±13.9 110.2±16.8
Group F, fentanyl group; Group FK, fentanyl plus ketamine group.
Values are mean±SD or number of patients.
Table 2. Postoperative Pain Scores Using the Visual Ana-
logue Scale (VAS) 
Time after surgery Group F (n=30) Group FK (n=30)
 1 hr 3.3±0.7  3.1±0.7
  6 hrs 2.9±0.7   2.5±0.6* 
12 hrs 2.5±0.7 2.2±0.6
24 hrs 1.9±0.5   1.4±0.5*
48 hrs 1.6±0.6   1.0±0.5*
Group F, fentanyl group; Group FK, fentanyl plus ketamine group. 
Values are mean±SD. 
*p<0.05 versus Group F.




Allocated to Group F 
(n=30)






Follow up (n=30) Follow up (n=30)
Analysis (n=30) Analysis (n=30)
Excluded (n=5)
 -Not meeting inclusion criteria (n=3)
 -Meeting exclusion criteria (n=2)Moon Ho Cha, et al.
Yonsei Med J   http://www.eymj.org   Volume 53   Number 2   March 2012 430
yl in IV-PCA, which has been shown to be effective for pain 
control with fewer side effects after the Nuss procedure in 
pediatric patients.3   
Ketamine has analgesic properties in subanesthetic dos-
es.5,7 Small doses of ketamine act specifically to prevent 
opioid tolerance and pain sensitization.7 Low-dose ket-
amine is defined as a single injection of less than 1 mg/kg 
or continuous infusion of less than 20 μg/kg/min.12 The in-
cidence of psychomimetic effects and cognitive impairment 
is negligible at doses less than 2.5 μg/kg/min and increases 
with higher doses of ketamine.12 It has been reported that a 
2.5 μg/kg/min infusion of ketamine on IV-PCA can de-
crease morphine consumption and the incidence of nau-
sea.13 Therefore, we decided to test a basal infusion rate of 
ketamine at 2.5 μg/kg/min (=0.15 mg/kg/hr). 
In review, Subramaniam, et al.14 concluded that a small 
dose of ketamine is a safe and useful adjuvant to standard 
IV or epidural opioid-analgesia, however, adding ketamine 
to IV-PCA with morphine showed no beneficial effect in 
postoperative pain control. Subsequently, conflicting results 
exist concerning the potential benefits of adding ketamine 
to opioids in IV-PCA for postoperative pain control.8-20 The 
results can be categorized by several types of surgery. 
For thoracic surgery, Nesher, et al.8,15 studied patients un-
dergoing thoracotomy and reported that a bolus of 5 mg of 
ketamine plus 1 mg of morphine IV-PCA (lockout 7 min) 
resulted in a reduction in pain score and a 45-50% reduc-
tion in morphine consumption with cardiovascular stability 
and better respiratory parameters. Michelet, et al.9 studied 
patients undergoing thoracic surgery and reported that add-
ing ketamine 1 mg/mL to morphine 1 mg/mL IV-PCA (a 
bolus of 0.015 mL/kg per every 10 min) resulted in reduc-
tions in morphine consumption and pain score and a reduc-
tion in nocturnal desaturation. 
The benefit of adding ketamine to morphine in IV-PCA 
for orthopedic surgery remains unclear. Javery, et al.16 stud-
ied patients undergoing lumbar microdiscectomy and re-
ported that ketamine 1 mg/mL added to morphine 1 mg/mL 
IV-PCA (bolus 1 mL, lockout 6 min) reduced pain scores 
and halved morphine consumption. Kollender, et al.17 stud-
ied patients undergoing orthopedic-oncological surgery and 
found that a bolus of 5 mg ketamine plus 1 mg morphine 
IV-PCA (lockout 7 min) resulted in a 60% reduction in 
morphine consumption and reductions in pain score and ad-
ditional analgesic use. However, Sveticic, et al.10 studied 
patients undergoing major orthopedic surgery and reported 
that a bolus of 1.5 mg ketamine plus 1.5 mg morphine in 
The incidence of nausea/vomiting was 23% in Group 
FK, significantly lower than 53% in Group F (p<0.05) (Ta-
ble 4). The number of patients who required the antiemetic, 
ondansetron, during the 48 hours after surgery was 3 (10%) 
in Group FK, significantly lower than 11 patients (37%) in 
Group F (p<0.05). The degree of pruritus was not severe, 
and the incidence of pruritus was not different between the 
two groups (Table 4). There were no reports of respiratory 
depression, hallucination, or dreaming in either group (Ta-
ble 4). No patients required administration of naloxone or 
chlorophenyramine. The number of parents satisfied with 
pain control was 25 (83%) in Group F and 28 (93%) in Group 
FK, and the difference was not significant. 
DISCUSSION
In our study, administration of IV-PCA with fentanyl plus 
low-dose ketamine resulted in reductions of the fentanyl 
consumption and pain scores as well as a decrease in nau-
sea/vomiting over fentanyl alone. 
Opioids in IV-PCA are used widely in the management of 
severe postoperative pain after the Nuss procedure.2-4 Control 
of severe pain requires more opioids. However, higher doses 
of opioids are associated with significant side effects in-
cluding respiratory depression, nausea/vomiting, sedation, 
constipation, urinary retention, as well as acute tolerance. In 
our study, we infused a basal rate of 0.5 μg/kg/hr of fentan-
Table 3. Cumulative Fentanyl Consumption (μg) after the 
Surgery 
Time after surgery Group F (n=30) Group FK (n=30)
 1 hr   31.2±9.6   27.5±8.1
  6 hrs 158.8±43.6 140.1±38.3
12 hrs 306.6±87.9 264.3±78.8
24 hrs 565.4±153.6 481.7±141.3*
48 hrs   1138.9±304.2 886.0±253.6*
Group F, fentanyl group; Group FK, fentanyl plus ketamine group.
Values are mean±SD.
*p<0.05 versus Group F.
Table 4. Incidence of Side Effects
Group F (n=30) Group FK (n=30)
Nausea/Vomiting  16 (53)      7 (23)*
Pruritus   4 (13)  2 (7)
Respiratory depression 0 (0) 0 (0)
Hallucination 0 (0) 0 (0)
Dreaming 0 (0) 0 (0)
Group F, fentanyl group; Group FK, fentanyl plus ketamine group. 
Values are number of patients (%). 
*p<0.05 versus Group F.Effects of Adding Ketamine to Fentanyl IV-PCA
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amine, could induce nausea/vomiting. In our study, 2.5 μg/
kg/min of ketamine, was low enough to avoid emetic ef-
fects. The incidence of patients who used the antiemetic, 
ondansetron, during the 48 hours after surgery was 10% in 
the fentanyl plus ketamine group and was lower than 37% 
in the fentanyl group. 
Pruritus is a common side effect of opioid administration, 
however, the incidence and severity is lower in the IV route 
than in the epidural or intrathecal route.22 The incidence of 
pruritus is 0-10% when fentanyl IV-PCA is used after the 
Nuss procedure.2,3 In our study, the incidence of pruritus 
was 13% in the fentanyl group and 7% in the fentanyl plus 
ketamine group. Although, the incidence was almost two 
times higher in the fentanyl group than in the fentanyl plus 
ketamine group, the incidences of both groups were too 
low to differentiate with statistical significance in either 
group. There were no instances of severe pruritus which re-
quired treatment in both groups. 
Thoracic surgery can lead to respiratory depression due 
to severe pain, inhibiting thoracic expansion while breath-
ing. Adequate analgesia to reduce postoperative pain en-
hances the ability to breathe deeply and cough effectively, 
alleviating respiratory depression.23 However, opioids in 
large doses can worsen respiration rates, oxygenation, and 
ventilation. Therefore, a reasonable amount of opioids and 
adjuvant to opioids are important to pain control as well as 
respiration. High doses of ketamine can have respiratory 
depressive effects, but respiratory depression associated 
with small doses of ketamine is minimal.8,9,15,21 Ketamine 
also sustains the patency of small and large airways, thus 
preventing obstruction, including the kind that can occur in 
patients under the effect of opioids. In our study, the infu-
sion rates of 0.5 μg/kg/hr of fentanyl and 0.15 mg/kg/hr of 
ketamine were low enough to avoid respiratory depression. 
These features lead to better respiration and a probable 
preservation of more than 90% of pulse oximetry saturation 
during the postoperative period. 
Ketamine is associated with a risk of psychomimetic ef-
fects, including hallucination, vivid dreaming, sedation, and 
dizziness. However, the safety of adding low-dose ketamine 
to morphine for postoperative IV-PCA regarding its psy-
chomimetic effects is well established.8,13,15,17,18 Badrinath, 
et al.21 investigated the dose-dependent effects of ketamine 
and reported that a dose of 24 μg/kg/min can increase psy-
chomimetic effects. Edwards, et al.24 used a dose-finding 
approach to study the combination of morphine and ket-
amine in IV-PCA for postoperative pain in elderly patients 
IV-PCA (lockout 8 min) failed to demonstrate beneficial ef-
fects in morphine consumption and pain control. 
The benefit of adding ketamine to morphine in IV-PCA 
for abdominal surgery also remains unclear. Adriaenssens, 
et al.13 studied patients undergoing abdominal surgery and 
reported that continuous infusion of ketamine 2.5 μg/kg/
min with morphine IV-PVA (loading dose 3 mg, bolus 1 
mg, lockout 8 min) reduced pain score and morphine con-
sumption. Unlügenç, et al.18 studied patients after major ab-
dominal surgery and found that ketamine 1 mg/mL added 
to tramadol 5 mg/mL IV-PCA (loading dose 1 mg/kg, bolus 
0.2 mg/kg, lockout 20 min, background infusion 0.4 mg/
kg/h) improved analgesia and reduced tramadol consump-
tion. However, investigating patients undergoing total ab-
dominal hysterectomy, Murdoch, et al.19 did not find any 
benefit of adding ketamine 0.75 mg/mL to morphine 1 mg/
mL IV-PCA (10 mL/m2 body surface area of loading dose, 
bolus 1 mL, lockout 5 min, background infusion 1 mL/h). 
Reeves, et al.20 found no pain-reducing or morphine-spar-
ing benefits of ketamine bolus 1 mg/mL plus morphine 1 
mg/mL IV-PCA (bolus, lockout, and background infusions 
were determined by the anesthesiologists) in patients after 
major abdominal surgery. 
In our study, adding ketamine to fentanyl IV-PCA reduced 
the cumulative fentanyl consumption by approximately 
22%, reduced pain scores, and reduced additional analgesic 
use, with parent satisfaction in pain control. Although these 
reduction levels were different, the results appear to be in 
agreement with prior studies.8,9,13,15-18 We conclude that there 
is a benefit to adding ketamine to opioids for IV-PCA for 
thoracic surgery.8,9,15 However, controversies remain regard-
ing the benefits of adding ketamine to opioids for IV-PCA 
for abdominal and orthopedic surgery.10-14,16-20 These contra-
dictory results may reflect differences in the methodology of 
each study, degree of postoperative pain, nature of surgical 
procedure, and nature and source of postoperative pain.
There is a significant incidence of nausea/vomiting when 
fentanyl IV-PCA is used postoperatively after the Nuss pro-
cedure, observed in 30-50% pediatric patients.2-4 In our study, 
the incidence of nausea/vomiting was 53% in the fentanyl 
group and 23% in the fentanyl plus ketamine group. Our 
results agree with prior studies that adding ketamine to 
morphine IV-PCA reduces the incidence of nausea/vomit-
ing.13,15-17 However, nausea/vomiting can be induced by ket-
amine itself in a dose dependent pattern. Badrinath, et al.21 
investigated the dose-dependent effects of ketamine during 
propofol sedation and reported that 24 μg/kg/min of ket-Moon Ho Cha, et al.
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Ketamine spares morphine consumption after transthoracic lung 
and heart surgery without adverse hemodynamic effects. Pharma-
col Res 2008;58:38-44. 
16. Javery KB, Ussery TW, Steger HG, Colclough GW. Comparison 
of morphine and morphine with ketamine for postoperative anal-
gesia. Can J Anaesth 1996;43:212-5.
17. Kollender Y, Bickels J, Stocki D, Maruoani N, Chazan S, Nirkin 
A, et al. Subanaesthetic ketamine spares postoperative morphine 
and controls pain better than standard morphine does alone in or-
thopaedic-oncological patients. Eur J Cancer 2008;44:954-62.
18. Unlügenç H, Gündüz M, Ozalevli M, Akman H. A comparative 
study on the analgesic effect of tramadol, tramadol plus magne-
sium, and tramadol plus ketamine for postoperative pain manage-
ment after major abdominal surgery. Acta Anaesthesiol Scand 
2002;46:1025-30.
19. Murdoch CJ, Crooks BA, Miller CD. Effect of the addition of ket-
amine to morphine in patient-controlled analgesia. Anaesthesia 
2002;57:484-8.
20. Reeves M, Lindholm DE, Myles PS, Fletcher H, Hunt JO. Adding 
ketamine to morphine for patient-controlled analgesia after major 
abdominal surgery: a double-blinded, randomized controlled trial. 
Anesth Analg 2001;93:116-20.
21. Badrinath S, Avramov MN, Shadrick M, Witt TR, Ivankovich 
AD. The use of a ketamine-propofol combination during moni-
tored anesthesia care. Anesth Analg 2000;90:858-62.
22. Werawatganon T, Charuluxanun S. Patient controlled intravenous 
opioid analgesia versus continuous epidural analgesia for pain af-
ter intra-abdominal surgery. Cochrane Database Syst Rev 2005: 
CD004088.
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and found that vivid dreaming was a problem at doses of 
ketamine of 7.8 μg/kg/min. The incidence of psychomimet-
ic symptoms associated with ketamine is lower in children 
than in adults.25 There were no hallucinations or cases of 
dreaming in our experiment. The dose of ketamine of 0.15 
mg/kg/hr (=2.5 μg/kg/min) was low enough to avoid psy-
chomimetic effects. 
To the best of our knowledge, this study is the first report 
on the effects of adding ketamine to fentanyl IV-PCA for 
postoperative pain control after the Nuss procedure in chil-
dren. We observed good parent satisfaction with pain con-
trol, reduced pain scores, reduced need for additional anal-
gesic, lower fentanyl consumption, reduced incidence of 
nausea/vomiting, and reduced need for antiemetics, without 
increased side effects. Therefore, if fentanyl IV-PCA is con-
sidered for postoperative pain control following the Nuss 
procedure in children, we recommend adding low-dose ket-
amine to the fentanyl IV-PCA. 
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